[Clinical analysis of a new triphasic estroprogestational combination with gestodene].
New steroidal compounds have been recently synthetized and analysed in order to improve the metabolic tolerance of oral contraception. Gestodene, a new progestogen from the 19 nortestosterone series seems to fulfil these conditions. It has also high antigonadotropic effects. The authors report the clinical results of a study with a triphasic combination containing Gestodene. Despite the small doses of hormones, this triphasic combination with Gestodene provides excellent contraceptive efficacy and good cycle control and clinical tolerance.